Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Organigram Holdings Inc. buy krebskrebs

Start price
€5.88
25.01.21 / 50%
Target price
€16.00
25.01.22
Performance (%)
-15.72%
End price
€4.95
26.01.22
Summary
This prediction ended on 26.01.22 with a price of €4.95. The prediction for Organigram Holdings Inc. disappointed with a performance of -15.72%. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Organigram Holdings Inc. -5.357% -5.357% -10.382% -82.082%
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

Comments by krebskrebs for this prediction

In the thread Organigram Holdings Inc. diskutieren
Prediction Buy
Perf. (%) -15.72%
Target price 4.000
Change
Ends at

Buy mit Kursziel 4,0

In the thread Trading Organigram Holdings Inc.
Prediction Buy
Perf. (%) -15.72%
Target price 4.000
Change
Ends at 25.01.22

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten